Tinambacan, Dante D.

HRN: 19-06-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2022
CEFTRIAXONE 1G (VIAL)
11/19/2022
11/26/2022
INTRAVENOUS
2 Grams
OD
Acute Appendicitis
Waiting Final Action 
11/19/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/19/2022
11/26/2022
INTRAVENOUS
500 Mg
Q8h
Acute Appendicitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: